Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.35 |
| ▸ | SELP | P16109 | 8/20 | 0.35 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.34 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.34 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.34 |
| ▸ | SELE | P16581 | 3/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ANTXR2 | P58335 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16360907 | 0.90 | LGALS3 (0.41) | ALDH1A1HPGDLGALS3SELPLGALS9 | |
| SCHEMBL15966246 | 0.90 | MAOB (0.42) | LGALS3SELPLGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL15966245 | 0.86 | PRKCA (0.38) | LGALS3SELPLGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL15473995 | 0.83 | LGALS3 (0.47) | LGALS3SELPLGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL12454166 | 0.83 | LGALS3 (0.47) | LGALS3SELPLGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL14685786 | 0.83 | LGALS3 (0.47) | LGALS3SELPLGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL17178184 | 0.83 | ALDH1A1 (0.51) | ALDH1A1HPGDLGALS3LGALS9LGALS1 | |
| SCHEMBL15966237 | 0.81 | MAOB (0.45) | LGALS3SELPLGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL15966260 | 0.80 | ANTXR2 (0.42) | LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB | |
| SCHEMBL8575549 | 0.80 | ALDH1A1 (0.49) | ALDH1A1HPGDPOLBGAAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140235850-A1 | SYNTHESIS OF HMO CORE STRUCTURES | GLYCOM A/S (DK) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235850-A1 | SYNTHESIS OF HMO CORE STRUCTURES | GNE, OGT, GALE | ALDH1A1 1436/4885HPGD 237/4885LGALS3 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.